$CIHN As anticipated, RBS is averaging 3 to 5 applicants per week during its initial rollout period. Eight patients have now been fully qualified, and three are ready to go to the DR in the next two weeks, for their procedures to commence under the guidance of Dr. Liriano.
(0)
(0)
BioStem Technologies, Inc. (BSEM) Stock Research Links